全文获取类型
收费全文 | 4203篇 |
免费 | 113篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 36篇 |
儿科学 | 71篇 |
妇产科学 | 26篇 |
基础医学 | 154篇 |
口腔科学 | 82篇 |
临床医学 | 573篇 |
内科学 | 1248篇 |
皮肤病学 | 93篇 |
神经病学 | 152篇 |
特种医学 | 90篇 |
外科学 | 414篇 |
综合类 | 219篇 |
预防医学 | 382篇 |
眼科学 | 53篇 |
药学 | 621篇 |
中国医学 | 65篇 |
肿瘤学 | 59篇 |
出版年
2024年 | 11篇 |
2023年 | 114篇 |
2022年 | 157篇 |
2021年 | 208篇 |
2020年 | 195篇 |
2019年 | 190篇 |
2018年 | 183篇 |
2017年 | 116篇 |
2016年 | 69篇 |
2015年 | 55篇 |
2014年 | 208篇 |
2013年 | 196篇 |
2012年 | 145篇 |
2011年 | 171篇 |
2010年 | 154篇 |
2009年 | 137篇 |
2008年 | 111篇 |
2007年 | 104篇 |
2006年 | 92篇 |
2005年 | 66篇 |
2004年 | 35篇 |
2003年 | 48篇 |
2002年 | 39篇 |
2001年 | 30篇 |
2000年 | 20篇 |
1999年 | 25篇 |
1998年 | 16篇 |
1997年 | 24篇 |
1996年 | 15篇 |
1995年 | 13篇 |
1994年 | 11篇 |
1993年 | 9篇 |
1992年 | 9篇 |
1990年 | 7篇 |
1988年 | 7篇 |
1987年 | 8篇 |
1986年 | 7篇 |
1985年 | 63篇 |
1984年 | 132篇 |
1983年 | 151篇 |
1982年 | 120篇 |
1981年 | 113篇 |
1980年 | 119篇 |
1979年 | 112篇 |
1978年 | 118篇 |
1977年 | 55篇 |
1976年 | 102篇 |
1975年 | 81篇 |
1974年 | 92篇 |
1973年 | 68篇 |
排序方式: 共有4338条查询结果,搜索用时 15 毫秒
61.
目的探讨高龄患者围手术期安全护理管理。方法通过参加术前病例讨论,了解病情,准备齐全手术物品,手术前访视与患者沟通建立良好的护患关系,术中认真细致的配合和耐心、细心的护理保证围手术的安全。结果对326例〉80岁高龄患者围手术期采取安全护理管理,使患者顺利渡过围手术期。结论手术前参加病例讨论,访视患者和术中细致、耐心、细心的安全护理措施保证了高龄患者手术恢复顺利。 相似文献
62.
加强高校化学实验物品管理的探讨 总被引:1,自引:0,他引:1
化学实验物品数量众多,品种繁杂,主要包括材料、低值品和易耗品等三大类。作为高校物资管理人员应增强信息观念、市场观念,不断加强理论和实践的学习,全面提高自身素质,搞好物资管理工作。同时,高校物资管理部门应完善物资管理制度,加强科学管理,为教学、科研工作提供有力保障和优质服务,为高校的发展做出应有的贡献。 相似文献
63.
《Occupational Therapy in Health Care》2013,27(1-2):257-259
Describes the “seasons” of professional life and conscious decision-making regarding role changes. 相似文献
64.
Adrian Baranchuk Marwan M. Refaat Kristen K. Patton Mina K. Chung Kousik Krishnan Valentina Kutyifa Gaurav Upadhyay John D. Fisher Dhanunjaya R. Lakkireddy 《Journal of the American College of Cardiology》2018,71(11):1284-1288
Medical devices have been targets of hacking for over a decade, and this cybersecurity issue has affected many types of medical devices. Lately, the potential for hacking of cardiac devices (pacemakers and defibrillators) claimed the attention of the media, patients, and health care providers. This is a burgeoning problem that our newly electronically connected world faces. In this paper from the Electrophysiology Section Council, we briefly discuss various aspects of this relatively new threat in light of recent incidents involving the potential for hacking of cardiac devices. We explore the possible risks for the patients and the effect of device reconfiguration in an attempt to thwart cybersecurity threats. We provide an outline of what can be done to improve cybersecurity from the standpoint of the manufacturer, government, professional societies, physician, and patient. 相似文献
65.
Kurt J. Pfeifer Angela Selzer Carlos E. Mendez Christopher M. Whinney Barbara Rogers Vinaya Simha Dennis Regan Richard D. Urman Karen Mauck 《Mayo Clinic proceedings. Mayo Clinic》2021,96(6):1655-1669
Perioperative medical management is challenging due to the rising complexity of patients presenting for surgical procedures. A key part of preoperative optimization is appropriate management of long-term medications, yet guidelines and consensus statements for perioperative medication management are lacking. Available resources utilize the recommendations derived from individual studies and do not include a multidisciplinary focus or formal consensus. The Society for Perioperative Assessment and Quality Improvement (SPAQI) identified a lack of authoritative clinical guidance as an opportunity to utilize its multidisciplinary membership to improve evidence-based perioperative care. SPAQI seeks to provide guidance on perioperative medication management that synthesizes available literature with expert consensus. The aim of this Consensus Statement is to provide practical guidance on the preoperative management of endocrine, hormonal, and urologic medications. A panel of experts with anesthesiology, perioperative medicine, hospital medicine, general internal medicine, and medical specialty experience was drawn together and identified the common medications in each of these categories. The authors then utilized a modified Delphi approach to critically review the literature and generate consensus recommendations. 相似文献
66.
67.
I. Aiza-Haddad A. Ballesteros-Amozurrutia O.D. Borjas-Almaguer M. Castillo-Barradas G. Castro-Narro N. Chávez-Tapia R.A. Chirino-Sprung L. Cisneros-Garza M. Dehesa-Violante J. Flores-Calderón A. Flores-Gaxiola I. García-Juárez M.S. González-Huezo E.I. González-Moreno F. Higuera-de la Tijera D. Kershenobich-Stalnikowitz E. López-Méndez R. Malé-Velázquez F. Bosques-Padilla 《Revista de gastroenterologia de Mexico》2018,83(3):275-324
The aim of the Mexican Consensus on the Treatment of Hepatitis C was to develop clinical practice guidelines applicable to Mexico. The expert opinion of specialists in the following areas was taken into account: gastroenterology, infectious diseases, and hepatology. A search of the medical literature was carried out on the MEDLINE, EMBASE, and CENTRAL databases through keywords related to hepatitis C treatment. The quality of evidence was subsequently evaluated using the GRADE system and the consensus statements were formulated. The statements were then voted upon, using the modified Delphi system, and reviewed and corrected by a panel of 34 voting participants. Finally, the level of agreement was classified for each statement. The present guidelines provide recommendations with an emphasis on the new direct-acting antivirals, to facilitate their use in clinical practice. Each case must be individualized according to the comorbidities involved and patient management must always be multidisciplinary. 相似文献
68.
Steve Rockman Dorit Becher Allison Dyson Sandra Koernig Adriana Baz Morelli Megan Barnden Sarina Camuglia Peter Soupourmas Martin Pearse Eugene Maraskovsky 《Vaccine》2014
In Australia, during the 2010 Southern Hemisphere (SH) influenza season, there was an unexpected increase in post-marketing adverse event reports of febrile seizures (FS) in children under 5 years of age shortly after vaccination with the CSL 2010 SH trivalent influenza vaccine (CSL 2010 SH TIV) compared to previous CSL TIVs and other licensed 2010 SH TIVs. In an accompanying study, we described the contribution to these adverse events of the 2010 SH influenza strains as expressed in the CSL 2010 SH TIV using in vitro cytokine/chemokine secretion from whole blood cells and induction of NF-κB activation in HEK293 reporter cells. The aim of the present study was to identify the root cause components that elicited the elevated cytokine/chemokine and NF-κB signature. Our studies demonstrated that the pyrogenic signal was associated with a heat-labile, viral-derived component(s) in the CSL 2010 SH TIV. Further, it was found that viral lipid-mediated delivery of short, fragmented viral RNA was the key trigger for the increased cytokine/chemokine secretion and NF-κB activation. It is likely that the FS reported in children <5 years were due to a combination of the new influenza strains included in the 2010 SH TIV and the CSL standard method of manufacture preserving strain-specific viral components of the new influenza strains (particularly B/Brisbane/60/2008 and to a lesser extent H1N1 A/California/07/2009). These combined to heighten immune activation of innate immune cells, which in a small proportion of children <5 years of age is associated with the occurrence of FS. The data also demonstrates that CSL TIVs formulated with increased levels of splitting agent (TDOC) for the B/Brisbane/60/2008 strain can attenuate the pro-inflammatory signals in vitro, identifying a potential path forward for generating a CSL TIV indicated for use in children <5 years. 相似文献
69.
《Vaccine》2017,35(45):6166-6171
For administration of multiple live attenuated vaccines, the Advisory Committee on Immunization Practices recommends either simultaneous immunization or period of at least 28 days between vaccines, due to a possible reduction in the immune response to either vaccine.The main objective of this study was to compare the immune response to measles (alone or combined with mumps and rubella) and yellow fever vaccines among infants aged 6–24 months living in a yellow fever non-endemic country who had received measles and yellow fever vaccines before travelling to a yellow fever endemic area.Subjects and methods: A retrospective, multicenter case-control study was carried out in 7 travel clinics in the Paris area from February 1st 2011 to march 31, 2015. Cases were defined as infants immunized with the yellow fever vaccine and with the measles vaccine, either alone or in combination with mumps and rubella vaccine, with a period of 1–27 days between each immunization. For each case, two controls were matched based on sex and age: a first control group (control 1) was defined as infants having received the measles vaccine and the yellow fever vaccine simultaneously; a second control group (control 2) was defined as infants who had a period of more than 27 days between receiving the measles vaccine and yellow fever vaccine.The primary endpoint of the study was the percentage of infants with protective immunity against yellow fever, measured by the titer of neutralizing antibodies in a venous blood sample.Results: One hundred and thirty-one infants were included in the study (62 cases, 50 infants in control 1 and 19 infants in control 2). Of these, 127 (96%) were shown to have a protective titer of yellow fever antibodies. All 4 infants without a protective titer of yellow fever antibodies were part of control group 1.Discussion: The measles vaccine, alone or combined with mumps and rubella vaccines, appears to have no influence on humoral immune response to the yellow fever vaccine when administered between 1 and 27 days. The absence of protective antibodies against yellow fever was observed only among infants who received both vaccines simultaneously.Conclusion: These results may support a revision of current vaccination recommendations concerning the administration of these two live attenuated vaccines either on the same day or at least 28 days apart. Our findings show no statistically significant difference if the interval between both vaccines is more than 24 h, but the immune response seems to be reduced when the two vaccines are given at the same time. 相似文献
70.